Linked Life Data

8321930

Source:http://linkedlifedata.com/resource/pubmed/id/8321930

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-8-3
pubmed:abstractText
The evidence indicates an increased prevalence and likely also an increased incidence of both renal and extrarenal malignancy in ESRD patients. With the exception of nonHodgkin's lymphoma, these are the same solid tumors commonly found in the general population. Although the overall change in tumor frequency may be small, certain tumors such as prostate carcinoma, cutaneous melanoma, and uterine carcinoma are significantly increased in the setting of renal failure. Better detection secondary to closer medical surveillance of the dialysis population may contribute in part to the increased prevalence. The increased prevalence of renal cancer is unique because of its development as a complication of prolonged azotemia in the setting of ACKD. This calls for additional renal imaging such as contrast-enhanced CT scanning along with other established screening procedures.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0270-9295
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
306-14
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Development of malignancy in the end-stage renal disease patient.
pubmed:affiliation
Division of Nephrology, University of Kansas Medical Center, Kansas City.
pubmed:publicationType
Journal Article, Review